The Immigration Exemption and the GDPR
Will the UK government’s controversial immigration exemption will be removed from the Data Protection Act? Here's why it matters
2nd March 2021
Web Exclusives
Creating visible and valuable vaccine content
How pharma companies can create digital content that satisfies demand and meets Google’s specific criteria for keeping users safe
2nd March 2021
A new focus
Castleman disease (CD) is a rare and potentially life-threatening disease. Like so many rare diseases, it is often misdiagnosed, or goes undiagnosed. On Rare Disease Day, EUSA Pharma’s Jon Morgan, VP global head of Medical, discusses the need to bring a new focus to rare diseases like CD
28th February 2021
A call to action
If we want to beat COVID-19, vaccination must be an urgent global effort
22nd February 2021
Tackling two crises at once
A look at the benefits of using cardboard packaging in the transport of vaccines
18th February 2021
A collaborative approach
Success is usually not a linear process – home treatments for COVID-19, in tandem with an effective vaccine, could place a large dent into this pandemic
17th February 2021
Are we actually all COVIDiots?
Is the general public still in the dark on the science of COVID?
12th February 2021
Smarter use of tech to aid HCPs
The role of smart technology in improving the wellbeing of doctors and pharmacists
4th February 2021
Finding the silver lining
To mark World Cancer Day, Sandoz' Professor Michael Wiechmann outlines the impact of the pandemic on cancer patients
4th February 2021
Turning to Google
22% of Brits are buying OTC medicines online after self-diagnosing via the internet
3rd February 2021
Digital transformation in the CDMO market
By investing in new tech platforms CDMOs can dramatically increase efficiency in process development and manufacture of ever-more complex therapeutics
3rd February 2021
Is pharma passing the test on access to medicine?
COVID-19 threw pharma’s performance on access to medicine into the spotlight. Has the industry passed the test?
27th January 2021
Opportunities for health tech in 2021
Where we might see growth drive innovation in the healthcare industry amid COVID-19 and beyond
25th January 2021
A threat to innovation?
Could recent legal decisions on Supplementary Protection Certificates (SPCs) prove to be a hammer blow for the pharma industry?
14th January 2021
